Ralph D Sanderson Selected Research

Ralph D Sanderson Research Topics

Disease

60	Neoplasms (Cancer) 03/2024 - 01/2002
33	Neoplasm Metastasis (Metastasis) 03/2024 - 12/2003
16	Multiple Myeloma 01/2023 - 10/2002
12	Inflammation (Inflammations) 01/2022 - 10/2010
7	Breast Neoplasms (Breast Cancer) 03/2024 - 10/2004
6	Osteolysis 01/2020 - 07/2005
3	Bone Diseases (Bone Disease) 01/2023 - 10/2002
3	Infections 01/2022 - 03/2012
3	Bone Resorption 11/2017 - 07/2005
3	Carcinoma (Carcinomatosis) 11/2016 - 06/2006
2	Virus Diseases (Viral Diseases) 01/2022 - 12/2020
2	Carcinogenesis 01/2020 - 04/2014
2	Lymphoma (Lymphomas) 11/2016 - 02/2005
2	Atherosclerosis 06/2013 - 06/2013
1	Hypoxia (Hypoxemia) 01/2023
1	Sepsis (Septicemia) 01/2022
1	COVID-19 01/2022
1	Vascular Diseases (Vascular Disease) 01/2022
1	Lewis Lung Carcinoma 01/2020
1	Idiopathic Pulmonary Fibrosis 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Disease Progression 01/2019
1	Fibrosis (Cirrhosis) 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 11/2016
1	Sarcoma (Soft Tissue Sarcoma) 11/2016
1	Herpes Simplex 04/2015
1	Pathologic Processes 04/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2014
1	Vascular System Injuries 06/2013
1	Myocardial Infarction 06/2013
1	Thrombosis (Thrombus) 06/2013
1	Carotid Artery Diseases 06/2013
1	Atherosclerotic Plaque (Atheroma) 06/2013
1	Osteoporosis 11/2010
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2010

Drug/Important Bio-Agent (IBA)

43	heparanaseIBA 03/2024 - 12/2003
24	Syndecan-1 (Syndecan 1)IBA 12/2020 - 01/2002
23	Heparitin Sulfate (Heparan Sulfate)IBA 07/2023 - 12/2003
21	EnzymesIBA 01/2023 - 12/2003
14	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2022 - 07/2002
11	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 07/2002
10	Proteoglycans (Proteoglycan)IBA 01/2016 - 12/2003
6	Glycoside Hydrolases (Endoglycosidases)IBA 01/2022 - 06/2013
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 01/2009
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015 - 10/2004
3	CytokinesIBA 01/2022 - 02/2011
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2011
3	Conditioned Culture MediaIBA 01/2016 - 06/2010
3	Sulfates (Sulfates, Inorganic)IBA 01/2008 - 10/2004
2	roneparstatIBA 01/2022 - 01/2016
2	AnticoagulantsIBA 01/2022 - 01/2008
2	LigandsIBA 11/2017 - 05/2011
2	OsteoprotegerinIBA 11/2017 - 10/2002
2	Monoclonal AntibodiesIBA 11/2016 - 06/2006
2	Fibronectins (Fibronectin)IBA 01/2016 - 04/2013
2	NF-kappa B (NF-kB)IBA 01/2016 - 04/2015
2	Small Interfering RNA (siRNA)IBA 04/2014 - 11/2012
2	perlecanIBA 05/2011 - 02/2004
2	Complementary DNA (cDNA)IBA 02/2011 - 12/2003
2	Indicators and Reagents (Reagents)IBA 09/2009 - 11/2008
2	heparitinsulfate lyaseIBA 09/2007 - 05/2007
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	VaccinesIBA 01/2022
1	Angiopoietin-2IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Cytostatic AgentsIBA 11/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	ChromatinIBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017
1	1,7- dioxa- 2,6- diaza- 4,7a- dithia- 3H,5H- benzo(cd)pentaleneIBA 01/2016
1	carfilzomibIBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	Bortezomib (Velcade)FDA Link 01/2016
1	Histones (Histone)IBA 01/2015
1	Metalloproteases (Metalloproteinases)IBA 04/2014
1	ChemokinesIBA 04/2014
1	ElementsIBA 11/2013
1	CoagulantsIBA 06/2013
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2012
1	Insulin ReceptorIBA 11/2012
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 09/2011
1	SyndecansIBA 05/2011
1	GlypicansIBA 05/2011
1	SST 0001IBA 03/2011
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2011
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 02/2011
1	GlucuronidaseIBA 02/2011
1	IntegrinsIBA 03/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2010
1	Protein Kinases (Protein Kinase)IBA 10/2009

Therapy/Procedure

19	Therapeutics 07/2023 - 12/2003
9	Drug Therapy (Chemotherapy) 11/2020 - 04/2014
2	Subcutaneous Injections 11/2020 - 02/2005
1	Precision Medicine 03/2024